ReviewCureus2024
Clinical Neuroscience Research in Saudi Arabia: A Comparative Evaluation of Performance at Country and Worldwide Levels Based on the Relative Specialization Index.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review is an appraisal of the performance of clinical neuroscience research in Saudi Arabia based on the measurement of the Relative Specialization Index (RSI). The latter is an established quantitative performance indicator that determines whether a country has a relatively higher or lower share in world publications in a specialty than its overall part in the world total publications. The study aimed to assess the trends in the specialty's RSI, comparing it to other medical specialties in Saudi Arabia and to that of the top 50 countries worldwide in clinical neuroscience. SCImago Journal and Country Rank were used to determine the total articles and total citations for 46 medical specialties in Saudi Arabia and clinical neuroscience in the worldwide top 50 countries during 1996‑ 2023. The RSI was calculated for each medical specialty and each country. A positive or negative RSI implied that the specialty's share in the country's total documents or total citations was higher or lower than the average for the specialty worldwide. A steady increase in Saudi Arabia's total articles and total citations in clinical neuroscience was observed over the last 28 years. The RSI values, however, remained negative throughout except for limited periods (2003-2006 for total articles) and (1996 and 1998 for total citations). Compared to other medical specialties in Saudi Arabia, the specialization performance for clinical neuroscience was within the mid-range in total articles (ranking 30
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.